Global Stomach Medicine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Stomach Medicine Market Research Report 2024
Stomach Medicine refers to medicines for stomach pain. It is mainly designed to neutralize stomach acid, relieve or prevent heartburn, flatulence, acid indigestion and other symptoms caused by hyperacidity
According to Mr Accuracy reports’s new survey, global Stomach Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Stomach Medicine market research.
Key companies engaged in the Stomach Medicine industry include Pfizer, Novartis, Teva Pharmaceutical Industries, Merck, Celltrion Healthcare, Mylan NV, F. Hoffmann La Roche, Bristol Myers Squibb Company and Eli Lilly and Company, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Stomach Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Stomach Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Stomach Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer
Novartis
Teva Pharmaceutical Industries
Merck
Celltrion Healthcare
Mylan NV
F. Hoffmann La Roche
Bristol Myers Squibb Company
Eli Lilly and Company
Roche
Bayer
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co., Ltd.
Segment by Type
Antacids
Acid Suppressant
Anti-Helicobacter Pylori Drug
Gastric Mucosal Protective Drug
Prokinetic Drug
Others
Heartburn
Stomach Ulcer
Excess Stomach Acid
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Stomach Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Stomach Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Stomach Medicine market research.
Key companies engaged in the Stomach Medicine industry include Pfizer, Novartis, Teva Pharmaceutical Industries, Merck, Celltrion Healthcare, Mylan NV, F. Hoffmann La Roche, Bristol Myers Squibb Company and Eli Lilly and Company, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Stomach Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Stomach Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Stomach Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Novartis
Teva Pharmaceutical Industries
Merck
Celltrion Healthcare
Mylan NV
F. Hoffmann La Roche
Bristol Myers Squibb Company
Eli Lilly and Company
Roche
Bayer
TAIHO PHARMACEUTICAL CO., LTD.
Jiangsu Hengrui Medicine Co., Ltd.
Segment by Type
Antacids
Acid Suppressant
Anti-Helicobacter Pylori Drug
Gastric Mucosal Protective Drug
Prokinetic Drug
Others
Segment by Application
Heartburn
Stomach Ulcer
Excess Stomach Acid
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Stomach Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source